Please assess the completion status of the following clinical trial:

Trial Title: Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Resistant Hypertension \> 140 / \> 90mmHg~* Inclusion age : 45 +~* Regular monitoring of blood levels considered~* pre-medication to lower blood pressure for at least 3 weeks before the preliminary investigation consistent~* Men and Women~Exclusion Criteria:~* derailed diabetes~* renal impairment , renal creatinine clear \<50 ml~* Non - austherapierte cancer / tumor patients~* Non - adjusted thyroid dysfunction~* BMI\> 35~* LVEF \<limit (  35%  )~* Peripheral AVK ( ABI - measurement ) \> Stage II~* regurgitation \> Stage I~* abdominal aneurysm~* infections~* acute febrile infections with temperature \> 38.5 ° C~* COPD and asthma to stage III~* dyspnea NYHA \> Stage III~* z.n. Stroke shorter than 12 weeks~* Acute liver failure~* Acute Apoplexy~* Severe poisoning~* drug addiction~* hyperthyroidism~* Hypotension~* hypocalcemia~* hypoglycemia~* ozone allergy~* pregnancy~* clotting problems ( hemophilia )~* pre-existing condition with hemoglobin \< 9mg/dl~* Fresh myocardial infarction~* Internal bleeding~* thrombocytopenia~* Acute alcohol~* Citrus allergy when using sodium citrate

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).